Suppr超能文献

辐射诱导平衡是肿瘤细胞增殖和 T 细胞介导的杀伤之间的平衡。

Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing.

机构信息

Department of Radiation and Cellular Oncology, The Ludwig Center for Metastasis Research, University of Chicago, Chicago, IL 60637, USA.

出版信息

J Immunol. 2013 Jun 1;190(11):5874-81. doi: 10.4049/jimmunol.1202612. Epub 2013 Apr 29.

Abstract

Local failures following radiation therapy are multifactorial, and the contributions of the tumor and the host are complex. Current models of tumor equilibrium suggest that a balance exists between cell birth and cell death due to insufficient angiogenesis, immune effects, or intrinsic cellular factors. We investigated whether host immune responses contribute to radiation-induced tumor equilibrium in animal models. We report an essential role for immune cells and their cytokines in suppressing tumor cell regrowth in two experimental animal model systems. Depletion of T cells or neutralization of IFN-γ reversed radiation-induced equilibrium, leading to tumor regrowth. We also demonstrate that PD-L1 blockade augments T cell responses, leading to rejection of tumors in radiation-induced equilibrium. We identify an active interplay between tumor cells and immune cells that occurs in radiation-induced tumor equilibrium and suggest a potential role for disruption of the PD-L1/PD-1 axis in increasing local tumor control.

摘要

放射治疗后局部失败是多因素的,肿瘤和宿主的贡献是复杂的。目前的肿瘤平衡模型表明,由于血管生成不足、免疫效应或内在细胞因素,细胞的出生和死亡之间存在平衡。我们研究了宿主免疫反应是否有助于动物模型中的放射诱导肿瘤平衡。我们报告了在两个实验动物模型系统中,免疫细胞及其细胞因子在抑制肿瘤细胞再生长方面的重要作用。耗尽 T 细胞或中和 IFN-γ 可逆转放射诱导的平衡,导致肿瘤再生长。我们还证明,PD-L1 阻断增强了 T 细胞反应,导致放射诱导平衡中的肿瘤排斥。我们确定了肿瘤细胞和免疫细胞之间在放射诱导肿瘤平衡中发生的积极相互作用,并提出了破坏 PD-L1/PD-1 轴在增加局部肿瘤控制中的潜在作用。

相似文献

1
Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing.
J Immunol. 2013 Jun 1;190(11):5874-81. doi: 10.4049/jimmunol.1202612. Epub 2013 Apr 29.
2
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
Cancer Res. 2013 Jun 15;73(12):3591-603. doi: 10.1158/0008-5472.CAN-12-4100. Epub 2013 Apr 30.
3
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6187-92. doi: 10.1073/pnas.1203479109. Epub 2012 Apr 2.
7
Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1.
Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):510-520. doi: 10.1016/j.ijrobp.2020.12.031. Epub 2020 Dec 29.
9
Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.
Cancer Immunol Res. 2017 Feb;5(2):127-136. doi: 10.1158/2326-6066.CIR-16-0293. Epub 2017 Jan 11.
10
Functional tumor specific CD8 + T cells in spleen express a high level of PD-1.
Int Immunopharmacol. 2020 Mar;80:106242. doi: 10.1016/j.intimp.2020.106242. Epub 2020 Jan 31.

引用本文的文献

1
YTHDFs as radiotherapy checkpoints in tumor immunity.
J Exp Med. 2025 Aug 4;222(8). doi: 10.1084/jem.20250272. Epub 2025 Jun 5.
5
Understanding the PULSAR effect in combined radiotherapy and immunotherapy using transformer-based attention mechanisms.
Front Oncol. 2024 Dec 2;14:1497351. doi: 10.3389/fonc.2024.1497351. eCollection 2024.
8
Synthesis, cytotoxicity and Tc-MIBI tumor cell uptake evaluation of 2-phenylbenzothiazole tagged triazole derivatives.
Future Med Chem. 2024;16(19):1999-2012. doi: 10.1080/17568919.2024.2389771. Epub 2024 Sep 4.
9
Radiotherapy and immunology.
J Exp Med. 2024 Jul 1;221(7). doi: 10.1084/jem.20232101. Epub 2024 May 21.
10
Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance.
Clin Cancer Res. 2024 Oct 1;30(19):4450-4463. doi: 10.1158/1078-0432.CCR-23-3616.

本文引用的文献

2
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
N Engl J Med. 2012 Jun 28;366(26):2455-65. doi: 10.1056/NEJMoa1200694. Epub 2012 Jun 2.
3
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
N Engl J Med. 2012 Jun 28;366(26):2443-54. doi: 10.1056/NEJMoa1200690. Epub 2012 Jun 2.
4
Immunologic correlates of the abscopal effect in a patient with melanoma.
N Engl J Med. 2012 Mar 8;366(10):925-31. doi: 10.1056/NEJMoa1112824.
5
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.
Nature. 2012 Feb 8;482(7385):400-4. doi: 10.1038/nature10755.
6
Expression of tumour-specific antigens underlies cancer immunoediting.
Nature. 2012 Feb 8;482(7385):405-9. doi: 10.1038/nature10803.
9
T cell exhaustion.
Nat Immunol. 2011 Jun;12(6):492-9. doi: 10.1038/ni.2035.
10
Genomic analysis of individual differences in ethanol drinking: evidence for non-genetic factors in C57BL/6 mice.
PLoS One. 2011;6(6):e21100. doi: 10.1371/journal.pone.0021100. Epub 2011 Jun 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验